Vital Therapies reported $-21224000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Enanta Pharmaceuticals ENTA:US USD -26348000 5.35M
Insmed INSM:US USD -131145000 35.5M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Omeros OMER:US USD -17456000 13.39M
Orasure Technologies OSUR:US USD 5.27M 24.08M
Regulus Therapeutics RGLS:US USD -7551000 293K
Revance Therapeutics RVNC:US USD -84693000 23.26M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
United Therapeutics UTHR:US USD 239.3M 123.3M
Vital Therapies VTL:US USD -21224000 677K
Xoma XOMA:US USD -4178000 492K